Drugs / Moringa oleifera leaf
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT04768829 | Feb → Sep 2021 | otomycosis | Deraya University | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05348824 | Aug 2022 → Mar 2023 | dental pulp necrosis | Cairo University | Unknown | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT06971055 | Jul → Sep 2025 overdue | dental caries, dental pulp necrosis, periapical periodontitis | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT06948526 | Jun 2025 → Jun 2026 overdue | — | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT05390099 | Apr → Jul 2022 | mouth disorder | Cairo University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04487613 Comparator | Mar 2021 → May 2022 | puerperal disorder | Chulalongkorn University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Moringa oleifera leaf | “Dietary Supplement: Moringa oleifera leaf” NCT05348824 ↗ |
| Known as | Moringa Oleifera Leaf Extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06971055 ↗ |
| Route | Oral | “Participants received Moringa oleifera leaf 450 mg capsule orally twice daily for 3 days.” NCT04487613 ↗ |